Economic analysis: investing in NCD prevention and management

Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals – The Lancet (free registration required)

See complete series: The Lancet Taskforce on NCDs and economics (free registration required for articles and commentaries)

“Economic case to #BeatNCDs: benefit-cost ratio of investing in prevention and treatment of #NCDs is 5.6 for economic returns – 10.9 if social returns are included” (via @TheLancet see Tweet)